No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
MNMD241220P9000
- 1.76
- 0.000.00%
15min DelayClose Dec 20 16:00 ET
0.00High0.00Low
1.76Open1.76Pre Close0 Volume27 Open Interest9.00Strike Price0.00Turnover0.00%IV-1.12%PremiumDec 20, 2024Expiry Date1.84Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma3.98Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Mind Medicine Price Target Announced at $20.00/Share by Chardan Capital
Mind Medicine Initiated at Buy by Chardan Capital
MindMed To Be Added To The Nasdaq Biotechnology Index, Effective At Market Open On December 23, 2024
MindMed to Be Added to the Nasdaq Biotechnology Index
Mind Medicine Analyst Ratings
Oppenheimer Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $20